Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
10.75
-0.52 (-4.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,177,760
Open
11.35
Bid (Size)
10.00 (1)
Ask (Size)
11.06 (5)
Prev. Close
11.27
Today's Range
10.71 - 11.45
52wk Range
9.760 - 56.37
Shares Outstanding
59,762,106
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 12, 2024
Via
Benzinga
Sage Therapeutics Reports Phase 2 Huntington's Data
June 11, 2024
On Tuesday before the market opened, Sage Therapeutics announced findings regarding Huntington's Disease (HD) based upon topline results from the Phase 2 SURVEYOR Study.
Via
Benzinga
Performance
YTD
-52.18%
-52.18%
1 Month
-3.85%
-3.85%
3 Month
-44.24%
-44.24%
6 Month
-51.62%
-51.62%
1 Year
-80.59%
-80.59%
More News
Read More
Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
June 11, 2024
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
May 29, 2024
Via
Benzinga
In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
April 18, 2024
Via
Benzinga
Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews
March 26, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Sunday, June 2
June 02, 2024
Via
Talk Markets
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
May 21, 2024
Via
Benzinga
Sage Therapeutics to Participate in Upcoming May Investor Conferences
May 07, 2024
From
Sage Therapeutics
Via
Business Wire
SAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024
April 25, 2024
Via
InvestorPlace
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
April 25, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 19, 2024
Via
Benzinga
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via
Benzinga
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 17, 2024
Via
Benzinga
Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
April 17, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
J B Hunt Transport Reports Downbeat Earnings, Joins ASML And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
April 17, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
April 11, 2024
From
Sage Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.